Both in Diagnostics
Celldex Therapeutics vs Lantheus Holdings
Over the past year CLDX returned +20.0% and LNTH returned +77.4%; their daily moves had a correlation of 0.22.
CLDX +20.0% LNTH +77.4%Growth of $1, one year, split-adjusted
| Metric | CLDX | LNTH |
|---|---|---|
| Price | $29.71 | $100.80 |
| Market cap | $2.33B | $6.58B |
| Today | +2.31% | +0.49% |
| 1 month | −8.8% | +0.6% |
| 6 months | −12.3% | +17.5% |
| Year to date | +9.4% | +51.5% |
| 1 year | +11.1% | +74.7% |
| Revenue growth (YoY) | −97.0% | +2.7% |
| Gross margin | 100.0% | 62.3% |
| Net margin | −334104.5% | 19.3% |
| P/E (TTM) | — | 23.9× |
| Price / sales | 14,766.5× | 4.2× |
| Net cash | $717.6M | $22.2M |
| Dividend yield | — | — |
| Volatility (60d) | 48.2% | 4.1% |
| Short % of float | 13.0% | 5.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).